SLC25A38
Basic information
Region (hg38): 3:39383370-39397351
Links
Phenotypes
GenCC
Source:
- sideroblastic anemia 2 (Definitive), mode of inheritance: AR
- sideroblastic anemia 2 (Strong), mode of inheritance: AR
- sideroblastic anemia 2 (Definitive), mode of inheritance: AR
- sideroblastic anemia 2 (Strong), mode of inheritance: AR
- autosomal recessive sideroblastic anemia (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Anemia, sideroblastic 2, pyridoxine-refractory | AR | Hematologic | Individuals may have chronic, transfusion-dependent anemia refractory to pyridoxine, and diagnosis may allow early transfusion-based treatment | Hematologic | 19412178; 21393332 |
ClinVar
This is a list of variants' phenotypes submitted to
- Sideroblastic anemia 2 (41 variants)
- not provided (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC25A38 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 22 | 26 | ||||
missense | 13 | 40 | 58 | |||
nonsense | 10 | 10 | ||||
start loss | 2 | |||||
frameshift | 13 | 16 | ||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 10 | |||||
splice region | 1 | 2 | 2 | 5 | ||
non coding | 17 | 25 | 24 | 66 | ||
Total | 43 | 7 | 63 | 50 | 25 |
Highest pathogenic variant AF is 0.0000460
Variants in SLC25A38
This is a list of pathogenic ClinVar variants found in the SLC25A38 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-39383400-G-C | Sideroblastic anemia 2 • X-linked sideroblastic anemia 1 | Uncertain significance (Jan 13, 2018) | ||
3-39383422-A-C | X-linked sideroblastic anemia 1 • Sideroblastic anemia 2 | Benign/Likely benign (Jun 28, 2018) | ||
3-39383433-G-A | X-linked sideroblastic anemia 1 • Sideroblastic anemia 2 | Conflicting classifications of pathogenicity (Jul 07, 2018) | ||
3-39383452-G-A | Sideroblastic anemia 2 | Likely benign (Jul 09, 2018) | ||
3-39383488-G-A | Sideroblastic anemia 2 • X-linked sideroblastic anemia 1 | Uncertain significance (Jan 12, 2018) | ||
3-39383498-G-A | X-linked sideroblastic anemia 1 • Sideroblastic anemia 2 | Uncertain significance (Jan 12, 2018) | ||
3-39383500-G-A | X-linked sideroblastic anemia 1 • Sideroblastic anemia 2 | Uncertain significance (Jan 13, 2018) | ||
3-39383506-T-C | X-linked sideroblastic anemia 1 • Sideroblastic anemia 2 | Uncertain significance (Jan 13, 2018) | ||
3-39383516-A-G | Refractory anemia with ringed sideroblasts • Sideroblastic anemia 2 | Benign/Likely benign (Jun 28, 2018) | ||
3-39383564-G-A | Sideroblastic anemia 2 • Refractory anemia with ringed sideroblasts | Uncertain significance (Jan 12, 2018) | ||
3-39383656-C-T | Sideroblastic anemia 2 • X-linked sideroblastic anemia 1 | Uncertain significance (Jan 12, 2018) | ||
3-39383686-G-C | Sideroblastic anemia 2 | Uncertain significance (Mar 16, 2018) | ||
3-39383710-C-A | Sideroblastic anemia 2 | Uncertain significance (Jan 12, 2018) | ||
3-39383725-A-G | Uncertain significance (Dec 01, 2021) | |||
3-39383726-T-C | SLC25A38-related disorder | Uncertain significance (Jan 01, 2019) | ||
3-39383735-A-G | Sideroblastic anemia 2 | Conflicting classifications of pathogenicity (Sep 25, 2024) | ||
3-39383736-C-T | X-linked sideroblastic anemia 1 • Sideroblastic anemia 2 | Conflicting classifications of pathogenicity (Jun 01, 2024) | ||
3-39383738-C-G | Pathogenic (May 17, 2023) | |||
3-39383742-T-G | Likely benign (Jan 06, 2024) | |||
3-39383745-G-A | Likely benign (Jul 27, 2022) | |||
3-39383748-G-T | Likely benign (Jun 15, 2022) | |||
3-39383749-C-T | Likely benign (Jun 16, 2023) | |||
3-39383758-C-T | Inborn genetic diseases | Uncertain significance (Jan 04, 2024) | ||
3-39383767-G-A | Uncertain significance (Jul 10, 2023) | |||
3-39383778-G-A | Likely benign (Oct 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC25A38 | protein_coding | protein_coding | ENST00000273158 | 7 | 14004 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000943 | 0.794 | 125671 | 0 | 77 | 125748 | 0.000306 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.263 | 162 | 172 | 0.943 | 0.0000104 | 1951 |
Missense in Polyphen | 63 | 73.511 | 0.85701 | 816 | ||
Synonymous | 0.537 | 60 | 65.5 | 0.916 | 0.00000392 | 646 |
Loss of Function | 1.26 | 10 | 15.3 | 0.653 | 9.04e-7 | 166 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000691 | 0.000691 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000457 | 0.000457 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Mitochondrial glycine transporter that imports glycine into the mitochondrial matrix. Plays an important role in providing glycine for the first enzymatic step in heme biosynthesis, the condensation of glycine with succinyl-CoA to produce 5-aminolevulinate (ALA) in the mitochondrial matrix. Required during erythropoiesis. {ECO:0000255|HAMAP-Rule:MF_03064, ECO:0000269|PubMed:19412178, ECO:0000269|PubMed:27476175}.;
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.653
- rvis_EVS
- 0
- rvis_percentile_EVS
- 53.73
Haploinsufficiency Scores
- pHI
- 0.214
- hipred
- N
- hipred_score
- 0.351
- ghis
- 0.525
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.847
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc25a38
- Phenotype
- growth/size/body region phenotype;
Gene ontology
- Biological process
- heme biosynthetic process;erythrocyte differentiation;glycine import into mitochondrion
- Cellular component
- mitochondrion;mitochondrial inner membrane;integral component of membrane
- Molecular function
- glycine transmembrane transporter activity